Skip to main content
Equibles

Katina Dorton

Board Member

Prelude Therapeutics Inc (PRLD)

Equibles does not estimate personal net worth.

Get an email with a short summary when Prelude Therapeutics Inc publishes a filing, an earnings call transcript or a press release.

Get PRLD alerts

About Katina Dorton

Katina Dorton is recorded as Board Member at Prelude Therapeutics Inc (PRLD) since October 17, 2025. Prelude Therapeutics Inc reported in an 8-K filed October 17, 2025 that Katina Dorton was appointed Class III director, effective October 17, 2025. Prelude Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Prelude Therapeutics Inc includes Krishna Vaddi (CEO and Board Member), Bryant D. Lim (CFO), Julian C. Baker (Board Member) and 2 others.

“On October 17, 2025, upon the recommendation of the Nominating and Corporate Governance Committee (the "NGC Committee") of the Board, the Board appointed Katina Dorton, J.D., MBA, as a Class III director effective as of the Effective Date.”
Prelude Therapeutics Inc Form 8-K, filed October 17, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Prelude Therapeutics Inc

Recent activity